D. E. Shaw & Co., Inc. Ac Immune Sa Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.04 - $8.37 $88,884 - $123,172	-14,716 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.32 - $8.96 $20,237 - $34,083	3,804 Added 34.86%	14,716 $112,000
Q4 2020 Feb 16, 2021	BUY	$4.47 - $5.58 $48,776 - $60,888	10,912 New	10,912 $56,000
Q3 2020 Nov 16, 2020	SELL	$4.78 - $9.06 $158,500 - $300,420	-33,159 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$6.57 - $8.3 $77,230 - $97,566	-11,755 Reduced 26.17%	33,159 $223,000
Q1 2020 May 15, 2020	BUY	$4.24 - $9.89 $190,435 - $444,199	44,914 New	44,914 $310,000

28.2M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $282M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.